Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study

Novartis Investigative Site, Taipei

Novartis Investigative Site, Auckland

Novartis Investigative Site, Sofia

Novartis Investigative Site, Melbourne

Novartis Investigative Site, Leuven

Novartis Investigative Site, Taipei

Novartis Investigative Site, George Town

Novartis Investigative Site, Taipei

Novartis Investigative Site, A Coruña

Novartis Investigative Site, Rozzano

Novartis Investigative Site, Milan

Novartis Investigative Site, Milan

Novartis Investigative Site, Milan

Maryland Oncology Hematology P A, Rockville

Novartis Investigative Site, Monza

Novartis Investigative Site, Bergamo

Novartis Investigative Site, Brescia

Novartis Investigative Site, Madrid

Novartis Investigative Site, Madrid

Novartis Investigative Site, Novara

Novartis Investigative Site, Málaga

Novartis Investigative Site, Aviano

Novartis Investigative Site, Taoyuan District

Novartis Investigative Site, Bologna

Novartis Investigative Site, Taichung

Novartis Investigative Site, Modena

Novartis Investigative Site, Saint-Herblain

Novartis Investigative Site, Essen

Novartis Investigative Site, Meldola

Novartis Investigative Site, Cologne

Novartis Investigative Site, Strasbourg

Novartis Investigative Site, Heidelberg

Highlands Oncology Group, Fayetteville

Novartis Investigative Site, Paris

Novartis Investigative Site, Paris

University of Colorado Cancer Center, Aurora

Novartis Investigative Site, Napoli

Loma Linda University, Loma Linda

Novartis Investigative Site, Regensburg

Novartis Investigative Site, Kuching

Novartis Investigative Site, Villejuif

Novartis Investigative Site, Würzburg

Novartis Investigative Site, Beijing

Novartis Investigative Site, Moscow

Novartis Investigative Site, Changchun

Novartis Investigative Site, Beirut

Novartis Investigative Site, Singapore

Novartis Investigative Site, Saint Petersburg

Novartis Investigative Site, Saint Petersburg

Novartis Investigative Site, Montería

Novartis Investigative Site, Taichung

Novartis Investigative Site, Guangzhou

Novartis Investigative Site, Guangzhou

Novartis Investigative Site, Guangzhou

Novartis Investigative Site, Hong Kong

Novartis Investigative Site, Pokfulam

Essex Oncology of North Jersey PA, Belleville

Novartis Investigative Site, Natal

Novartis Investigative Site, Porto Alegre

Novartis Investigative Site, Barretos

Novartis Investigative Site, São Paulo

Novartis Investigative Site, Brno

Novartis Investigative Site, Perugia

Novartis Investigative Site, Nagoya

Novartis Investigative Site, Fukuoka

Novartis Investigative Site, Akashi

Novartis Investigative Site, Koto Ku

Novartis Investigative Site, Gdansk

Novartis Investigative Site, Seoul

Novartis Investigative Site, Seoul

Novartis Investigative Site, Seoul

Novartis Investigative Site, Barcelona